Suchergebnisse - "De Jong, Dirk"

PubPharm (13)

1

Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy

enthalten in: Digestive diseases and sciences | 2023

von Jansen, F. | Smits, L. | Thomas, P. | +5

2

Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Kreijne, J. | de Vries, A. | de Veer, R. | +9

CommentIn: Aliment Pharmacol Ther. 2020 Sep;52(5):910. - PMID 32852819

3

Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease : myelotoxicity and hepatotoxicity rarely affect maintenance treatment

enthalten in: Alimentary pharmacology & therapeutics | 2019

von Kreijne, J. | de Veer, R. | de Boer, N. | +7

4

Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2019

von Sluiter, R. | Van Marrewijk, C. | De Jong, D. | +11

5

Patients' beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases

enthalten in: European journal of gastroenterology & hepatology | 2018

von Broekman, M. | Coenen, M. | Wanten, G. | +11

6

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

enthalten in: Inflammatory bowel diseases | 2017

von Broekman, M. | Coenen, M. | van Marrewijk, C. | +10

7

Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2017

von Wong, D. | Coenen, M. | Vermeulen, S. | +11

8

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

enthalten in: Gastroenterology | 2015

von Coenen, M. | de Jong, D. | van Marrewijk, C. | +113

CommentIn: Gastroenterology. 2015 Oct;149(4):850-3. - PMID 26311276

9

Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro

enthalten in: Cell biology and toxicology | 2015

von Broekman, M. | Roelofs, H. | Wong, D. | +6

10

Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease

enthalten in: Gut | 2014

von Jharap, B. | de Boer, N. | Stokkers, P. | +9